Authors
John W. Winkleman, MD, PhD, is Chief of the Sleep Disorders Clinical Research Program in the Department of Psychiatry at Massachusetts General Hospital. Winkleman also served as chair of the committee that updated the guidelines. Winkelman has spent 30 years in RLS treatment and research; this includes consulting with leading nonprofits, research organizations and pharmaceutical companies, including Azurity Pharmaceuticals, Disc Medicine, Emalex, and Noctrix for which he is a paid consultant.
Winkelman received his PhD in Psychobiology from Harvard University, an MD from Harvard Medical School and then completed both a residency in Psychiatry and a fellowship in Sleep Medicine at Massachusetts General Hospital.
Full Bio: https://www.massgeneral.org/doctors/19403/john-winkelman
Joshua Mali, MD, is a board-certified ophthalmologist and award-winning vitreoretinal surgeon at The Eye Associates, a private multi-specialty ophthalmology practice in Sarasota, Florida. He is the Retina Medical Director of the Macular Degeneration Association (MDA).
Brian LaMoreaux, MD, MS, is a rheumatologist and Senior Medical Director at Horizon Therapeutics.
Kitsios is an assistant professor of medicine in the division of pulmonary, allergy, critical care and sleep medicine at the University of Pittsburgh.
Chris Wincup, MBBS, BSc, is a consultant Rheumatologist specializing in lupus and vasculitis at King's College Hospital.
Stone is professor of medicine at Harvard Medical School and the Edward A Fox Chair in Medicine at the Massachusetts General Hospital. He has treated IgG4-related disease (IgG4-RD) since its emergence in recent years and is passionate about educating patients and fellow healthcare providers (HCPs) about the indolent and systemic nature of this disease.
Hope on the Horizon: The Future of GCA Treatment
Mia Baumgartner is a Master’s Student in Forensic Psychology at the University of Denver with interests in neuropsychology and somatic therapy. In her first year, Baumgartner has been involved in traumatic brain injury research in the criminal justice system. She aims to work in prison reform or teach yoga in prisons.
Nicole Bundy is a board-certified rheumatologist and the Medical Director at Mymee, a pioneer in self-evidence-based research for people who struggle with symptoms associated with long COVID and rheumatic autoimmune diseases.